Intensive Care Unit Management of Liver Transplant Patients: A Formidable Challenge for the Intensivist

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 3206-3208

  Saner, F H ^a   Sotiropoulos, G C ^a   Radtke, A ^a   Fouzas, I ^a,b   Molmenti, E P ^a   Nadalin, S ^a   Paul, A ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Aristotle University of Thessaloniki   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; ORNIPRESSIN; TERLIPRESSIN;

ARTICLE; HEALTH HAZARD; HEART FAILURE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG FUNCTION; PATHOPHYSIOLOGY; PATIENT CARE; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RESPIRATORY FAILURE;

HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; POSTOPERATIVE CARE; RESPIRATORY FUNCTION TESTS;

EID: 55749105684     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.069     Document Type: Article

References (23)

1. Saner F., Kavuk I., and Lang H. Postoperative ICU management in liver transplant patients. Eur J Med Res 8 (2003) 511
2. McGilvray I.D., and Greig P.D. Critical care of the liver transplant patient: an update. Curr Opin Crit Care 8 (2002) 178
3. Kowalski. The cardiac output in Laennec's cirrhosis. J Clin Invest 32 (1953) 1025
4. Pizcueta P., Pique J.M., and Fernandez M. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 103 (1992) 1909
5. Albillos A., Rossi I., and Cacho G. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol 268 (1995) G459
6. Ma ZLee S.S. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 24 (1996) 451
7. Briegel J., Forst H., and Haller M. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27 (1999) 723
8. Tsai M.H., Peng Y.S., and Chen Y.C. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 43 (2006) 673
9. Jones R.M., Moulton C.E., and Hardy K.J. Central venous pressure and its effect on blood loss during liver resection. Br J Surg 85 (1998) 1058
10. Schroeder R.A., Collins B.H., and Tuttle-Newhall E. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth 18 (2004) 438
11. Saner F.H., Pavlakovic G., and Gu Y. Effects of positive end-expiratory pressure on systemic haemodynamics, with special interest to central venous and common iliac venous pressure in liver transplanted patients. Eur J Anaesthesiol 23 (2006) 766
12. Yost C.S., Matthay M.A., and Gropper M.A. Etiology of acute pulmonary edema during liver transplantation: a series of cases with analysis of the edema fluid. Chest 119 (2001) 219
13. Brienza N., Revelly J.P., and Ayuse T. Effects of PEEP on liver arterial and venous blood flows. Am J Respir Crit Care Med 152 (1995) 504
14. Berendes E., Lippert G., and Loick H.M. Effects of positive end-expiratory pressure ventilation on splanchnic oxygenation in humans. J Cardiothorac Vasc Anesth 10 (1996) 598
15. Saner F.H., Pavlakovic G., and Gu Y. Does PEEP impair the hepatic outflow in patients following liver transplantation?. Intensive Care Med 32 (2006) 1584
16. Narayanan Menon K.V., Nyberg S.L., and Harmsen W.S. MELD and other factors associated with survival after liver transplantation. Am J Transplant 4 (2004) 819
17. Gines P., Guevara M., and Arroyo V. Hepatorenal syndrome. Lancet 362 (2003) 1819
18. Cardenas A., Uriz J., and Gines P. Hepatorenal syndrome. Liver Transpl 6 (2000) S63
19. Brensing K.A., Textor J., and Strunk H. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 349 (1997) 697
20. Guevara M., Gines P., and Bandi J.C. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 28 (1998) 416
21. Guevara M., Gines P., and Fernandez-Esparrach G. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27 (1998) 35
22. Uriz J., Gines P., and Cardenas A. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 33 (2000) 43
23. Gonwa T.A., Morris C.A., and Goldstein R.M. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation 51 (1991) 428